MALT lymphoma medical therapy

MALT lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating MALT Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Upper GI Endoscopy

MRI

Endoscopic Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

MALT lymphoma medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of MALT lymphoma medical therapy

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onMALT lymphoma medical therapy

CDC on MALT lymphoma medical therapy

MALT lymphoma medical therapy in the news

on MALT lymphoma medical therapy

Directions to Hospitals Treating MALT lymphoma

Risk calculators and risk factors for MALT lymphoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2], Ahmed Younes M.B.B.CH [3]

## Overview

[edit | edit source]

The optimal therapy for MALT lymphoma depends on the stage at diagnosis. The treatment options for early stage (localized) gastric MALT lymphoma include antibiotic therapy, radiotherapy, chemotherapy, surgery, and monoclonal antibodies.[1] The treatment options for advanced stage gastric MALT lymphoma include observation, radiotherapy, chemotherapy, and monoclonal antibodies.[1]

## Medical therapy

[edit | edit source]

The various treatment options for gastric MALT lymphoma include:[1]

Treatment of gastric
MALT lymphoma

|
|
|
|
|
|
|
|
|
|
|
|

Early stage
(localized)

Advanced stage

Antibiotic therapy

Radiation therapy

Surgery

Chemotherapy

Monoclonal antibodies

Observation

Radiotherapy

Chemotherapy

Monoclonal antibodies

### Early Stage MALT lymphoma of the Stomach

[edit | edit source]

The treatment options for early stage (localized) gastric MALT lymphoma include:[1]

#### 1) Antibiotic therapy

[edit | edit source]

* Amoxicillin and other antibiotics are often the first treatment used for H. pylori infection in people with gastric lymphoma. They can be very effective in getting rid of H. pylori and causing the gastric lymphoma to go into remission. A combination of 2 or 3 antibiotics may be used.
* Antibiotics may be given with drugs that lower the production of acid in the stomach, called proton pump inhibitors (PPI) such as omeprazole or H2-receptor antagonists such as ranitidine.
* Antibiotics should be usually given for 10–14 days. This treatment is often very effective at shrinking the lymphoma. However, it can sometimes take several months for the treatment to be effective.
* After treatment with antibiotics, gastroscopy is performed to visualize if the H. pylori are gone, if the lymphoma has shrunk, or if the lymphoma has not recurred. This is an important part of follow-up after treatment with antibiotic therapy.

#### 2) Radiotherapy

[edit | edit source]

* External beam radiation therapy may be used if antibiotics don’t shrink the lymphoma or if the person is H. pylori negative.

#### 3) Surgery

[edit | edit source]

* Surgery for gastric MALT lymphoma (partial or total gastrectomy) is sometimes done if the lymphoma remains after antibiotic therapy or if the gastric lymphoma progresses.

#### 4) Chemotherapy

[edit | edit source]

* Chemotherapy is sometimes used if the lymphoma does not respond to antibiotic therapy. Drugs that may be used include single drugs such as chlorambucil, cyclophosphamide or combinations like CHOP – cyclophosphamide, doxorubicin, vincristine, and prednisone.

#### 5) Monoclonal Antibodies

[edit | edit source]

* Monoclonal antibodies are a type of biological therapy that is effective in treating certain types of NHL. Rituximab, the anti-CD20 chimeric antibody, may be another option if antibiotics do not reduce the lymphoma.

### Advanced Stage MALT lymphoma of the Stomach

[edit | edit source]

* More advanced gastric MALT lymphomas are often treated like follicular lymphoma. The treatment options for advanced stage gastric MALT lymphoma include:[1]

#### 1) Observation

[edit | edit source]

* People with gastric MALT lymphoma that is not progressing may be observed without being treated right away.

#### 2) Radiotherapy

[edit | edit source]

* External beam radiation therapy may be used if the lymphoma is large, causing symptoms, or growing.

#### 3) Chemotherapy

[edit | edit source]

* Chemotherapy may be used instead of radiation therapy if the lymphoma is large, growing, widespread, or recurs.
* Chemotherapy drugs used are the same as those used for follicular lymphoma. These include single drugs like chlorambucil, cyclophosphamide, fludarabine, or cladribine.
* Chemotherapy can also include combinations of chemotherapy drugs, such as:

* CVP – cyclophosphamide, vincristine, and prednisone
* CHOP – cyclophosphamide, doxorubicin, vincristine, and prednisone

#### 4) Monoclonal Antibodies

[edit | edit source]

* Rituximab, the anti-CD20 chimeric antibody, is another option if the gastric lymphoma is resistant to antibiotics, not associated with H. pylori infection, or if the lymphoma has relapsed.

If the disease is limited to the stomach (which is assessed with computed tomography), then 70-80% of patients will have a complete regression on treatment with antibiotic eradication of H. pylori. [2]

## References

[edit | edit source]

1. ↑ 1.0 1.1 1.2 1.3 1.4 Treatment of MALT lymphoma of the stomach. Canadian Cancer Society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/malt-lymphoma/?region=on. Accessed on January 28, 2016
2. ↑ Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M (1995). "Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group". Lancet. 345 (8965): 1591–4. PMID 7783535.CS1 maint: Multiple names: authors list (link)

Template:WikiDoc Sources